首页 | 本学科首页   官方微博 | 高级检索  
     

Asperphenamate衍生物的合成及体外抗乳腺癌活性评价
引用本文:袁雷,李云飞,孙铁民. Asperphenamate衍生物的合成及体外抗乳腺癌活性评价[J]. 中国药物化学杂志, 2010, 20(5): 336-341
作者姓名:袁雷  李云飞  孙铁民
作者单位:沈阳药科大学制药工程学院,辽宁 沈阳 110016
基金项目:国家自然科学基金项目(30472190)
摘    要:目的 设计合成天然产物asperphenamate衍生物。并对其体外抗人乳腺癌作用进行评价。方法 以L-苯丙氨酸为起始原料,经过4 步反应得到目标产物,其结构经核磁共振氢谱确证。采用MTT方法,以T47D和MDA-MB231细胞为实验瘤株进行体外抗乳腺癌活性测试。结果与结论 设计合成了27个新化合物。体外抗乳腺癌活性测试结果表明,化合物NPED-6和NPED-19的体外抗乳腺癌活性明显强于苯丙氨酸片段手性中心消旋的asperphenamate,它们的半数抑制浓度接近10 μmol·L-1

关 键 词:消旋化;asperphenamate;抗乳腺癌活性;MTT法
收稿时间:2010-06-07
修稿时间:2010-07-02

Synthesis of asperphenamate derivatives and their anti-breast cancer activity evaluation
YUAN Lei,LI Yun-fei,SUN Tie-min. Synthesis of asperphenamate derivatives and their anti-breast cancer activity evaluation[J]. Chinese Journal of Medicinal Chemistry, 2010, 20(5): 336-341
Authors:YUAN Lei  LI Yun-fei  SUN Tie-min
Affiliation:School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China
Abstract:Aim To design and synthesize some asperphenamate derivatives which the phenylalanine moiety racemized and to evaluate their anti-breast cancer activity in vitro.Methods Starting from L-phenylalanine,the target compounds were prepared through four steps.Their structures were confirmed by 1H-NMR.Their anti-breast cancer activities were evaluated by MTT method using the T47D and MDA-MB231 cell lines.Results and conclusion Twenty-seven compounds not reported were synthesized successfully.NPED-6 and NPED-19 show...
Keywords:racemization  asperphenamate  anti-breast cancer activity  MTT method
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国药物化学杂志》浏览原始摘要信息
点击此处可从《中国药物化学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号